CUTISS's Grant

CUTISS raised a round of funding on July 31, 2018. Investors include European Commission.

CUTISS developed the denovoSkin, a personalized bioengineered skin graft product for the treatment of a broad spectrum of skin defects.…

Articles about CUTISS's Grant: